Diabetes Mellitus prevalence in ME/CFS Patients
Introduction and background
Dr Eva Martin and Professor Elisa Oltra of the European ME Research Group (EMERG)
have observed that diabetes mellitus may be less prevalent in the group of ME patients that they have
in Spain (approx. 160)
compared to the general population.
They have proposed creating a short questionnaire whereby data can be obtained from patients anonymously.
Dr Martin has proposed a clinical trial for repurposing of a suitable drug which could be an inexpensive trial that could build into the further EMERG-European ME Clinicians research collaboration.
The reason to have the survey conducted first is to find out whether there are many ME patients with diabetes mellitus.
Some patients may be treated with these drugs already and if no effect has been observed with respect to fatigue, there would be no reason for the repurposed trial.
However, if the drug has not been much tested in ME patients due to the low prevalence of diabetes mellitus, then the repurposing of the drug may be interesting to explore.
So Dr Martin and Professor Oltra have asked the European ME Alliance (EMEA) to publicise this survey and invite all people with ME to respond.
Eventually the EMEA page will have the survey in additional languages - see here -
Take Part in the Survey
The data collection and publication of the survey will use Google Forms.
After collection and analysis of the data a report will be produced.
No personal data will be published or held.